Skip to main content
. 2018 Nov 30;12:460. doi: 10.3389/fncel.2018.00460

FIGURE 1.

FIGURE 1

Potentials of cellular reprogramming (A) in vitro and (B) in vivo for regenerative medicine, disease modeling, as well as drug discovery and testing gene therapy.